Company Information & Drug Savings for CV Therapeutics, Inc. Medications
CV Therapeutics, acquired by Gilead Sciences, was a pharmaceutical company focused on cardiovascular medicines. The company developed Ranexa (ranolazine) for chronic angina and Lexiscan (regadenoson) for cardiac stress testing. Gilead continues marketing these cardiovascular products while advancing heart disease research.
How to Contact CV Therapeutics, Inc.
Phone
1-650-384-8500Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
